Skip to main content
Equibles
UTMD logo

UTMD · Utah Medical Products Inc · Short Interest

Track UTMD — free

Use UTMD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research UTMD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$73.63 +0.60 (+0.82%) At close · Nov 12
Russell 2000 member Rebalance outlook locked
Market Cap
$234.42M
Shares
3.18M
Volume · Nov 12 13.08K Avg daily vol (3M) 36.51K

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Pull short interest history through the short interest API or MCP →

UTMD Latest Reported Short Interest

FINRA reported 151,293 UTMD shares sold short as of the October 30, 2026 settlement date, an increase of 11,078 shares. Days to cover was 3.90 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

UTMD Short Interest Forecast

Equibles' model estimates 158,277 shares sold short for the November 13, 2026 settlement, +4.6% versus the latest reported position, with a likely range of 132,236 to 188,942 shares. This model prediction uses FINRA data through November 11, 2026; FINRA's official release is expected November 24, 2026.

Model estimate

Expected Nov 13 short interest

as of Nov 11 High confidence 65% chance it rises
158,277 +4.6% vs reported
Likely range 132,236 to 188,942 The latest estimate appears in the chart below. Official release expected Nov 24. Methodology
Short Squeeze Score
71/100
Short interest 4.8% of shares — P70 Days to cover 3.9 — P56 Price vs VWAP +1.2% — P72 Short-volume trend +12.5% — P88 Short interest change +7.9% — P76 Worst FTD 0.06% of shares — P77

Positioning score 71.4 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-10-30). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

No active listed options were found.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-11-13 06:49 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-11-30 Scheduled
    FINRA publishes Dec 9
    		 — — — —
    2026-11-13 Scheduled
    FINRA publishes Nov 24
    		 — — — —
    2026-10-30 151,293 140,215 +11,078 3.90
    2026-10-15 140,215 151,912 -11,697 3.58
    2026-09-30 151,912 172,180 -20,268 4.79
    2026-09-15 172,180 166,805 +5,375 4.53
    2026-08-31 166,805 139,715 +27,090 4.03
    2026-08-14 139,715 135,579 +4,136 7.04
    2026-07-31 135,579 140,086 -4,507 3.37
    2026-07-15 140,086 138,696 +1,390 7.72
    2026-06-30 138,696 131,133 +7,563 6.79
    2026-06-15 131,133 113,014 +18,119 15.27
    2026-05-29 113,014 132,672 -19,658 9.43
    2026-05-15 132,672 126,681 +5,991 15.39
    2026-04-30 126,681 137,091 -10,410 9.86
    2026-04-15 137,091 131,281 +5,810 13.62
    2026-03-31 131,281 115,046 +16,235 7.26
    2026-03-13 115,046 110,620 +4,426 8.49
    2026-02-27 110,620 104,313 +6,307 5.35
    2026-02-13 104,313 100,649 +3,664 9.61
    2026-01-30 100,649 99,056 +1,593 6.64
    2026-01-15 99,056 96,464 +2,592 7.68
    2025-12-31 96,464 98,561 -2,097 6.63
    2025-12-15 98,561 101,923 -3,362 5.08
    2025-11-28 101,923 103,183 -1,260 8.21
    2025-11-14 103,183 106,079 -2,896 10.03

    Full FINRA short interest reporting calendar

    Showing 1–24 of 24 settlements
    Key facts CIK 706698 CUSIP 917488108 13F (30d) 82 filings 69 filers Visit website Investor relations